Phase II FK 506 multicenter concentration control study: one-year follow-up.
Laskow
D A
DA
University of Alabama, Birmingham 35294.
Vincenti
F
F
Neylan
J
J
Mendez
R
R
Matas
A
A
D000328:Adult; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D008297:Male; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use* / Q000633:toxicity*; D013997:Time Factors
D016559:Tacrolimus